The latest announcement is out from Fangdd Network Group ( (DUO) ).
MCARH109 is a first-in-class G protein–coupled receptor, class C, group 5, member D (GPRC5D)-targeted chimeric antigen receptor (CAR) T-cell therapy for patients with relapsed/refractory multiple ...
Modern Times Group MTG AB (publ) ("MTG") will transfer 6,194,343 class B shares in MTG to the founders of PlaySimple Games Private Limited ("PlaySimple") in January 2026 following a conversion of clas ...